ACADEMIC RHEUMATOLOGY AND CLINICAL IMMUNOLOGY
学术风湿病学和临床免疫学
基本信息
- 批准号:7242541
- 负责人:
- 金额:$ 35.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-07-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION(Provided by Applicant):
The overall goal of the Academic Rheumatology and Clinical Immunology Training Program at UCSF is to provide advanced research training to qualified individuals with MD, MD/PhD, or PhD degrees who plan to pursue careers in academic rheumatology. This program provides trainees with an environment in which they can: (1) pursue course work in a chosen area of concentration; (2) learn how to investigate a scientific problem in depth; (3) master state-of-the-art techniques; and (4) understand what constitutes good science.
Training in our program takes advantage of the resources of the Rheumatology Divisions at Moffitt-Long University Hospital, San Francisco General Hospital, and the San Francisco VA Medical Center. In addition, our training grant is one of the few, if not the only training grant that supports training in both adult and pediatric rheumatology/immunology. The integration of pediatric rheumatology into our training grant was a major goal of the current grant cycle, and it has produced one of the major achievements by preparing the first three pediatric trainees for faculty positions at top academic centers (Cornell, Colorado, and UCSF).
The UCSF program in Rheumatology and Clinical Immunology has diverse strengths that provide a broad range of opportunities for trainees. For over two decades, our program has had particular strength in two of the most rapidly developing areas of medical science - basic biomedical research, and health services research/outcomes research. These areas of strength are at the heart of the unprecedented recent advances in basic science and the important national debate and evolution in health care delivery. More recently, we have added two major new research programs: genetic epidemiology of rheumatic diseases, and clinical trials of novel biologic therapies for rheumatic diseases. This breadth of activity creates an outstanding environment for collaboration among faculty and trainees in the Departments of Medicine, Pediatrics, and Immunology. In this context, substantive interactions among basic scientists and clinical scientists, and among adult and pediatric rheumatologists, create an atmosphere of respect for all aspects of our discipline.
This training grant supports six highly qualified trainees through two or three years of rigorous scientific training, with the objective that they will devote their subsequent careers to the study of the rheumatic and immunologic diseases.
描述(申请人提供):
UCSF的学术流变学和临床免疫学培训计划的总体目标是为计划从事学术流变学职业的MD,MD/PhD或PhD学位的合格人员提供高级研究培训。该计划为学员提供了一个环境,使他们能够:(1)在选定的集中领域从事课程工作;(2)学习如何深入调查科学问题;(3)掌握最先进的技术;(4)了解什么是好的科学。
在我们的计划培训利用莫菲特-朗大学医院,旧金山弗朗西斯科总医院和旧金山弗朗西斯科VA医疗中心的流变学部门的资源。此外,我们的培训补助金是为数不多的,如果不是唯一的培训补助金,支持在成人和儿童风湿病学/免疫学的培训。将儿科风湿病学纳入我们的培训补助金是当前补助金周期的一个主要目标,它通过为顶级学术中心(康奈尔大学,科罗拉多和UCSF)的教师职位准备前三名儿科学员而取得了重大成就之一。
在流变学和临床免疫学的UCSF计划具有不同的优势,为学员提供了广泛的机会。二十多年来,我们的计划在医学科学发展最快的两个领域-基础生物医学研究和卫生服务研究/成果研究方面具有特别的优势。这些优势领域是基础科学前所未有的最新进展和重要的国家辩论和医疗保健提供的演变的核心。最近,我们增加了两个主要的新研究项目:风湿性疾病的遗传流行病学和风湿性疾病新生物疗法的临床试验。这种活动的广度为医学,儿科和免疫学系的教师和学员之间的合作创造了良好的环境。在这种情况下,基础科学家和临床科学家之间,以及成人和儿科风湿病学家之间的实质性互动,创造了尊重我们学科各个方面的氛围。
这项培训补助金支持六名高素质的受训人员通过两三年的严格科学培训,目的是使他们今后的职业生涯致力于风湿病和免疫疾病的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David I Daikh其他文献
David I Daikh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David I Daikh', 18)}}的其他基金
A Controlled Trial of CBT for MS Inflammation
CBT 治疗多发性硬化症炎症的对照试验
- 批准号:
7111692 - 财政年份:2003
- 资助金额:
$ 35.88万 - 项目类别:
A Controlled Trial of CBT for Multiple Sclerosis Inflammation
CBT 治疗多发性硬化症炎症的对照试验
- 批准号:
7287441 - 财政年份:2003
- 资助金额:
$ 35.88万 - 项目类别:
A Controlled Trial of CBT for Multiple Sclerosis Inflammation
CBT 治疗多发性硬化症炎症的对照试验
- 批准号:
8144984 - 财政年份:2003
- 资助金额:
$ 35.88万 - 项目类别:














{{item.name}}会员




